Author details

Full Name

Mehdi Mesri

Affiliation

ORCID

Career Start Year

1993

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37541199	Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.	Cell	2023
36973268	Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
37198186	Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
35296364	Development and psychometric properties of COVID-19 related Healthcare Student stress scale (CHSSS).	BMC psychology	2022
36205206	Evaluation and comparison of vitamin A supplementation with standard therapies in the treatment of patients with COVID-19.		2022
36266629	Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.	Clin Proteomics	2022
33417831	Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.	Cancer Cell	2021
33577785	Proteogenomic and metabolomic characterization of human glioblastoma.	Cancer Cell	2021
33787192	The effects of combination of and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: a randomized controlled trial.	Journal of Complementary and Integrative Medicine	2021
31923397	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2020
31147049	Reduced graphene oxide decorated on Cu/CuO-Ag nanocomposite as a high-performance material for the construction of a non-enzymatic sensor: Application to the determination of carbaryl and fenamiphos pesticides.	Materials Science and Engineering C	2019
31675502	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2019
31196969	Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.	Mol Cell Proteomics	2019
30584560	Hyper Acute Quadriplegia with Chronic Lead Toxicity; a Case Report.	Emergency	2018
27836980	Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.	Mol Cell Proteomics	2017
28348404	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
28440318	Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
29259637	Accelerated rigor mortis: A case letter.	Journal of Research in Medical Sciences	2017
26653538	Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.	J Proteome Res	2016
27251275	Proteogenomics connects somatic mutations to signalling in breast cancer.	Nature	2016
26867747	Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays.	Methods Mol Biol	2016
26860878	A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.	J Proteome Res	2016
26719571	Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.	Clin Chem	2016
26279647	Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium.	Clinical Proteomics	2015
25693799	Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.	Mol Cell Proteomics	2015
24972168	CPTAC Assay Portal: a repository of targeted proteomic assays.	Nat Methods	2014
26556407	Advances in Proteomic Technologies and Its Contribution to the Field of Cancer.		2014
26415346	Fingerprints: A simple method for Screening Hemophilic Patients.	Bangladesh Medical Research Council Bulletin	2014
25187343	Linking cancer genome to proteome: NCI's investment into proteogenomics.	Proteomics	2014
23689285	Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).	Mol Cell Proteomics	2013
24124232	Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.	Cancer Discov	2013
24036152	BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.	Molecular Immunology	2013
24063748	Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.	J Proteome Res	2013
24236063	Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues.	PLoS ONE	2013
20715861	Evolution of clinical proteomics and its role in medicine.	J Proteome Res	2011
29768786	Realizing individualized medicine: the road to translating proteomics from the laboratory to the clinic.	Per Med	2011
19858499	Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.	Mol Cell Proteomics	2010
21142883	A synopsis of the 3rd annual Cancer Proteomics Conference.	Expert Rev Proteomics	2010
21137031	Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.	Proteomics Clin Appl	2010
21133699	Restructuring proteomics through verification.	Biomark Med	2010
20007859	Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.	Clin Chem	2010
20007858	Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.	Clin Chem	2010
19837981	Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.	Mol Cell Proteomics	2010
19921851	Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.	J Proteome Res	2010
19561596	Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.	Nat Biotechnol	2009
18388126	Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients.	Molecular and Cellular Proteomics	2008
21716826	Gastrointestinal and urinary tract bleeding in methanol toxicity.	BMJ Case Reports	2008
16481347	Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins.	International Immunology	2006
12960137	Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.	Clin Cancer Res	2003
12855648	Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.	Clinical Cancer Research	2003